| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.007 | 0.9 |